Cysteine cathepsin S as an immunomodulatory target: present and future trends.
about
Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probesCanine uterine bacterial infection induces upregulation of proteolysis-related genes and downregulation of homeobox and zinc finger factorsRedefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of MrgprsCathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization.Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury.Influence of a prudent diet on circulating cathepsin S in humansAnalysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin SSerum cathepsin S is associated with decreased insulin sensitivity and the development of type 2 diabetes in a community-based cohort of elderly menThe immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunityIdentification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice.Activation of the immune response is a key feature of aging in mice.Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D).Cathepsin S inhibitors: 2004-2010.Inhibitors of cathepsin K: a patent review (2004 - 2010).Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors.Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming.
P2860
Q26827307-29CEB58E-53B0-45B1-B4FA-2F7CE3A835CDQ27335116-BAA1ACD6-B17D-41CF-B643-47744117E51BQ28265606-F2029DE5-3ADB-4A56-8423-015C857D6BDAQ33589216-95D0DBB1-909E-4C90-B5CE-AB2CE640E33DQ33765990-4AAA2705-1EBB-44F1-9B35-D39D128A4973Q34136197-4F98ED69-77FB-4F2F-B4C7-766B24641A2AQ34599128-AE7C8557-D282-4975-A16C-1DDA3FBBE4FAQ36477922-9B880D4F-6EB8-480D-A767-93DDF7913BC8Q37223894-EC31F337-28D1-45E4-96F3-2CF3C5A4163CQ37326645-5D00ED77-B934-47A7-A907-20D38A89CF49Q37424381-F688CAD6-93A5-4877-92D4-584EC35E3D3AQ37472038-D277F1B9-1C60-435D-A446-0BAF00C7E8C0Q37845839-B9E9C262-0D63-4D3F-B638-97375BD673D0Q37933395-983F736D-CF0E-4818-9DBE-58060C89EE2EQ40207781-E6B96119-54FF-4840-BC64-DDD353630EDBQ44550327-26F89ABF-5DFB-4974-930B-D01B1E7E6850Q51769088-CC9FE6E6-3480-47FD-9A3D-8C3D9C0E02E1
P2860
Cysteine cathepsin S as an immunomodulatory target: present and future trends.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cysteine cathepsin S as an immunomodulatory target: present and future trends.
@en
Cysteine cathepsin S as an immunomodulatory target: present and future trends.
@nl
type
label
Cysteine cathepsin S as an immunomodulatory target: present and future trends.
@en
Cysteine cathepsin S as an immunomodulatory target: present and future trends.
@nl
prefLabel
Cysteine cathepsin S as an immunomodulatory target: present and future trends.
@en
Cysteine cathepsin S as an immunomodulatory target: present and future trends.
@nl
P2093
P2860
P1476
Cysteine cathepsin S as an immunomodulatory target: present and future trends
@en
P2093
Abhijit Ray
Suman Gupta
Sunanda Dastidar
P2860
P304
P356
10.1517/14728222.12.3.291
P407
P577
2008-03-01T00:00:00Z